These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 26219343

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. In-vitro and in-vivo study of amorphous spironolactone prepared by adsorption method using supercritical CO2.
    Jiang Q, Li Y, Fu Q, Geng Y, Zhao J, Ma P, Zhang T.
    Drug Dev Ind Pharm; 2015 Feb; 41(2):201-6. PubMed ID: 24369091
    [Abstract] [Full Text] [Related]

  • 3. Increased dissolution rate and oral bioavailability of hydrophobic drug glyburide tablets produced using supercritical CO₂ silica dispersion technology.
    Guan J, Han J, Zhang D, Chu C, Liu H, Sun J, He Z, Zhang T.
    Eur J Pharm Biopharm; 2014 Apr; 86(3):376-82. PubMed ID: 24184803
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Application of scCO2 technology for preparing CoQ10 solid dispersion and SFC-MS/MS for analyzing in vivo bioavailability.
    Yang R, Li Y, Li J, Liu C, Du P, Zhang T.
    Drug Dev Ind Pharm; 2018 Feb; 44(2):289-295. PubMed ID: 29082762
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Preclinical pharmacokinetic evaluation of a new formulation of a bifendate solid dispersion using a supercritical fluid chromatography-tandem mass spectrometry method.
    Liu M, Zhao L, Yang D, Ma J, Wang X, Zhang T.
    J Pharm Biomed Anal; 2014 Nov; 100():387-392. PubMed ID: 25221916
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Enhancement of dissolution rate and oral absorption of a poorly water-soluble drug, K-832, by adsorption onto porous silica using supercritical carbon dioxide.
    Miura H, Kanebako M, Shirai H, Nakao H, Inagi T, Terada K.
    Eur J Pharm Biopharm; 2010 Oct; 76(2):215-21. PubMed ID: 20603215
    [Abstract] [Full Text] [Related]

  • 11. Dissolution-rate enhancement of fenofibrate by adsorption onto silica using supercritical carbon dioxide.
    Sanganwar GP, Gupta RB.
    Int J Pharm; 2008 Aug 06; 360(1-2):213-8. PubMed ID: 18550302
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Candesartan Cilexetil Formulations in Mesoporous Silica: Preparation, Enhanced Dissolution In Vitro, and Oral Bioavailability In Vivo.
    Guan H, Wang M, Yu S, Wang C, Chen Q, Chen Y, Zhang W, Fan J.
    J Pharm Sci; 2024 Oct 06; 113(10):3045-3053. PubMed ID: 39094942
    [Abstract] [Full Text] [Related]

  • 14. Improvement in oral bioavailability and dissolution of tanshinone IIA by preparation of solid dispersions with porous silica.
    Yan HM, Sun E, Cui L, Jia XB, Jin X.
    J Pharm Pharmacol; 2015 Sep 06; 67(9):1207-14. PubMed ID: 25944009
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Solid dispersion of berberine-phospholipid complex/TPGS 1000/SiO₂: preparation, characterization and in vivo studies.
    Zhang Z, Chen Y, Deng J, Jia X, Zhou J, Lv H.
    Int J Pharm; 2014 Apr 25; 465(1-2):306-16. PubMed ID: 24456672
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A novel strategy to design sustained-release poorly water-soluble drug mesoporous silica microparticles based on supercritical fluid technique.
    Li-Hong W, Xin C, Hui X, Li-Li Z, Jing H, Mei-Juan Z, Jie L, Yi L, Jin-Wen L, Wei Z, Gang C.
    Int J Pharm; 2013 Sep 15; 454(1):135-42. PubMed ID: 23871738
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Physicochemical and biopharmaceutical characterization of amorphous solid dispersion of nobiletin, a citrus polymethoxylated flavone, with improved hepatoprotective effects.
    Onoue S, Nakamura T, Uchida A, Ogawa K, Yuminoki K, Hashimoto N, Hiza A, Tsukaguchi Y, Asakawa T, Kan T, Yamada S.
    Eur J Pharm Sci; 2013 Jul 16; 49(4):453-60. PubMed ID: 23707470
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.